Internal MilestonesThe company was behind on internal milestones with respect to a major broadscale goal of quantifying a significant number of proteins from a complex sample.
Launch DelaysCommercial launch now expected in late-2026, delayed from late 2025, due to modifications needed on the assay configuration and surface chemistry.
Stock PerformanceNAUT traded down nearly (20%) after another commercial launch timeline delay, this one a push out to late 2026.